CBIO Price / Book | CRESCENT BIOPHARMA, INC.

CRESCENT BIOPHARMA, INC. (CBIO) Price / Book

2026-09-03: Price/Book Ratio 4.64.
2026-06-30: Price/Book Ratio 3.06.
2026-03-31: Price/Book Ratio 2.75.
2025-12-31: Price/Book Ratio 1.61.

Historical market capitalization divided by filed shareholder equity.

Available history: 2014-03-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	4.64
2026-06-30	3.06
2026-03-31	2.75
2025-12-31	1.61
2025-09-30	1.42
2025-06-30	1.61
2024-06-30	90
2024-03-31	668.79
2023-12-31	395.6
2023-09-30	207.43
2023-06-30	204.2
2023-03-31	130.18
2022-12-31	383.8
2022-09-30	59.92
2022-06-30	56.44
2022-03-31	86.7
2021-12-31	92.31
2021-09-30	117.34
2021-06-30	106.49
2021-03-31	123.98
2020-12-31	143.74
2020-09-30	106.2
2020-06-30	120.51
2020-03-31	66.92
2019-12-31	149.12
2019-09-30	111.85
2019-06-30	288.34
2019-03-31	279.07
2018-12-31	198.93
2018-09-30	284.82
2018-06-30	304.61
2018-03-31	289.71
2017-12-31	481.95
2017-09-30	421.87
2017-06-30	316.3
2017-03-31	406.25
2016-12-31	401.76
2016-09-30	394.97
2016-06-30	342.56
2016-03-31	330.51
2015-12-31	269.24
2015-09-30	218.89
2015-06-30	273.82
2015-03-31	356.51
2014-12-31	268.42
2014-09-30	227.22
2014-06-30	249.31
2014-03-31	554.09

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Indaptus Therapeutics, Inc. (INDP)	United States	$0.537B
Evolus, Inc. (EOLS)	United States	$0.519B	-13.32
ARVINAS, INC. (ARVN)	United States	$0.510B	58.38
PUMA BIOTECHNOLOGY, INC. (PBYI)	United States	$0.507B	15.53
CAPRICOR THERAPEUTICS, INC. (CAPR)	United States	$0.499B	-10.81
Ovid Therapeutics Inc. (OVID)	United States	$0.487B	-14.41
Phathom Pharmaceuticals, Inc. (PHAT)	United States	$0.572B	-8.76
ASSEMBLY BIOSCIENCES, INC. (ASMB)	United States	$0.481B	-13,053.96
Altimmune, Inc. (ALT)	United States	$0.593B	-6.43
Monopar Therapeutics (MNPR)	United States	$0.598B	-34.82